This inventor holds 1 USPTO granted patent. Top assignee: Orizuru Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kensuke Sakuma: Innovator in Insulin-Producing Cell Research
Introduction
Kensuke Sakuma is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing insulin-producing cells. His innovative approach aims to enhance the efficiency of cell differentiation processes.
Latest Patents
Kensuke Sakuma holds a patent for a growth inhibitor. The objective of this invention is to provide a method for removing non-endocrine unintended cells that coexist with insulin-secreting cells obtained through differentiation. This patent outlines a method for producing an insulin-producing cell population by treating the differentiated cells from pluripotent stem cells with a PLK inhibitor. He has 1 patent to his name.
Career Highlights
Kensuke Sakuma is currently associated with Orizuru Therapeutics, Inc., where he continues to advance his research in cell differentiation and insulin production. His work is pivotal in addressing challenges related to diabetes treatment and regenerative medicine.
Collaborations
Kensuke collaborates with notable colleagues, including Noriko Yamazoe and Taro Toyoda. Their combined expertise fosters a dynamic research environment that promotes innovation in the field.
Conclusion
Kensuke Sakuma's contributions to insulin-producing cell research exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile